Shanghai Xuerong Biotechnology Co.,Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 1,943.49 million compared to CNY 1,649.34 million a year ago. Revenue was CNY 1,943.49 million compared to CNY 1,649.34 million a year ago.

Net loss was CNY 128.01 million compared to net income of CNY 6.23 million a year ago. Basic loss per share from continuing operations was CNY 0.26 compared to basic earnings per share from continuing operations of CNY 0.01 a year ago. Diluted loss per share from continuing operations was CNY 0.26 compared to diluted earnings per share from continuing operations of CNY 0.01 a year ago.